Melanie Bella, director, Medicare-Medicaid Coordination Office, Centers for Medicare & Medicaid Services, says the sole focus of the Medicare-Medicaid Coordination Office is to increase coordination and access to services from many fronts.
Melanie Bella, director, Medicare-Medicaid Coordination Office, Centers for Medicare & Medicaid Services (CMS), says the sole focus of the Medicare-Medicaid Coordination Office is to increase coordination and access to services on many fronts. One way CMS is increasing access for dual eligibles is through the Program Alignment Initiative. It looks at programs and how they do or do not work together for beneficiaries.
“We are very focused on data, which may not sound like a direct benefit to beneficiaries, but getting Medicare data linked with Medicaid data and into the hands of care managers allows us to foster coordination and access for beneficiaries,” said Ms Bella.
CMS is also sponsoring demonstrations that integrate the full spectrum of Medicaid and Medicare services. These provide beneficiary enhancements so that beneficiaries are getting access to all the care they are entitled to under both programs.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More